Literature DB >> 8477797

The fate of human peripheral blood lymphocytes after transplantation into SCID mice.

G Martino1, J Anastasi, J Feng, C Mc Shan, L DeGroot, J Quintans, L M Grimaldi.   

Abstract

Human peripheral blood lymphocytes (hu-PBL) can be adoptively transferred by intraperitoneal injection into mice with severe combined immunodeficiency (SCID). The transplanted lymphocytes can produce immunoglobulin (Ig), respond to antigens, and survive for months in this chimeric model (hu-PBL SCID). However, whether the lymphocytes actually repopulate and reconstitute lymphoid structures and organs has been subject of some debate. To address this question and to characterize the hu-PBL SCID model better, we employed a novel technique for the identification of human cells in xenogeneic mice. We used fluorescence in situ hybridization (FISH) with a biotinylated DNA probe to all human centromeres. We demonstrated that FISH could be used to detect human cells when they accounted for less than 1% of human/mouse cell mixtures; it could also be employed for the identification and localization of individual human cells in tissue sections. By using FISH, we studied 31 SCID mice injected with 1.5 x 10(7)-4 x 10(7) hu-PBL via intravenous (i.v.) or intraperitoneal (i.p.) routes. In the 6 i.v.-injected mice, we found that the human cells were removed from the circulation into the lung within 1 h. In 22 of 25 i.p.-injected animals, 90-3716 micrograms/ml of human IgG was found in the sera at 3 to 13 weeks after transplantation (a.t.). Human cells colonized the peritoneal cavity and persisted for up to 13 weeks a.t. and, in the 12 mice studied, accounted for 4% to 57% of the cells in the peritoneal fluid. However, only rare, isolated human cells were found in the spleen, blood, bone marrow, lung or Peyer's patches. In 7 of 19 mice that received hu-PBL i.p. from Epstein-Barr virus-seropositive donors, we found masses of human cells usually beneath the peritoneal lining but sometimes infiltrating normal tissue. We conclude that FISH offers a simple means for accurate identification of human cells in the xenogeneic mouse. Although there is colonization of the peritoneal cavity in most mice, and development of lymphoid masses in some, there is no reconstitution of lymphoid structures and only minimal engraftment of lymphoid organs by human cells in conventionally-prepared hu-PBL SCID constructs.

Entities:  

Mesh:

Year:  1993        PMID: 8477797     DOI: 10.1002/eji.1830230506

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

Review 1.  SCID mice and the study of parasitic disease.

Authors:  K B Seydel; S L Stanley
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Identification of a multienzyme complex for glucose metabolism in living cells.

Authors:  Casey L Kohnhorst; Minjoung Kyoung; Miji Jeon; Danielle L Schmitt; Erin L Kennedy; Julio Ramirez; Syrena M Bracey; Bao Tran Luu; Sarah J Russell; Songon An
Journal:  J Biol Chem       Date:  2017-04-19       Impact factor: 5.157

3.  Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.

Authors:  L Covassin; J Laning; R Abdi; D L Langevin; N E Phillips; L D Shultz; M A Brehm
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

4.  Update of humanized animal disease models in studying Graft-versus-host disease.

Authors:  Feng Huang; Feng Lin Cao; Song Guo Zheng
Journal:  Hum Vaccin Immunother       Date:  2018-09-05       Impact factor: 3.452

5.  An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis.

Authors:  Bochao Wang; Yasuyuki Saito; Mitsuhiro Nishimura; Zhenxiao Ren; Lidya Handayani Tjan; Alaa Refaat; Rie Iida-Norita; Ryuko Tsukamoto; Masato Komatsu; Tomoo Itoh; Takashi Matozaki; Yasuko Mori
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

6.  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Authors:  Bruno Nervi; Michael P Rettig; Julie K Ritchey; Hanlin L Wang; Gerhard Bauer; Jon Walker; Mark L Bonyhadi; Ronald J Berenson; Julie L Prior; David Piwnica-Worms; Jan A Nolta; John F DiPersio
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

7.  Mature helper T cell requirement for immunoglobulin production by neonatal native B cells injected intraperitoneally into severe combined immunodeficient (SCID) mice.

Authors:  M Hasui; T Miyawaki; T Ichihara; Y Niida; K Iwai; A Yachie; H Seki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

8.  Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.

Authors:  D L Greiner; L D Shultz; J Yates; M C Appel; G Perdrizet; R M Hesselton; I Schweitzer; W G Beamer; K L Shultz; S C Pelsue
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

Review 9.  The SCID mouse: relevance as an animal model system for studying human disease.

Authors:  E A Hendrickson
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

10.  Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines.

Authors:  T R Kollmann; A Kim; X Zhuang; M Hachamovitch; H Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.